E1	Eq-Comparison:T1 Temporal-Period:T2
E2	Eq-Comparison:T3 Temporal-Period:T4
E3	Eq-Comparison:T5 Temporal-Period:T6
E4	Eq-Comparison:T7 Temporal-Period:T8
E5	Eq-Comparison:T9 Temporal-Period:T10
E6	Eq-Comparison:T11 Temporal-Period:T12
E7	Eq-Comparison:T13 Operator:T24 Temporal-Unit:T26 Value:T25
E8	Eq-Comparison:T15 Value:T16 Temporal-Unit:T61
E9	Condition:T18 Name:T19
E10	Procedure:T20 Name:T21
E11	Procedure:T22 Name:T23 Temporality:E7
E13	Study:T27 
E14	Age:T28 Numeric-Filter:E15
E15	Eq-Comparison:T29 Value:T30 Temporal-Unit:T31 Operator:T32 Value2:T33 Temporal-Unit2:T34
E16	Eq-Comparison:T35 Operator:T36 Value:T37 Temporal-Unit:T38
E17	Procedure:T39 Name:T40 Temporality:E1 Duration:E16
E18	Procedure:T41 Name:T42
E19	Modifier:T43 Modifies:T42
E20	Drug:T44 Name:T45
E21	Procedure:T46 Name:T47
E23	Observation:T49 Name:T50 Temporality:E2 Duration:E27 Numeric-Filter:E26
E24	Modifier:T51 Modifies:T50
E26	Eq-Comparison:T53 Operator:T54 Value:T55
E27	Eq-Comparison:T56 Operator:T57 Value:T58 Temporal-Unit:T59 Per:T60
E29	Study:T63 
E31	Assertion:T65 Asserted:E12
E33	Condition:T67 Name:T68
E34	Condition:T69 Name:T71
E38	Drug:T74 Name:T75
E39	Contraindication:T76 Contraindicates:E38
E40	Condition:T77 Name:T78
E41	Condition:T79 Name:T80
E42	Modifier:T81 Modifies:T80
E43	Modifier:T82 Modifies:T80
E44	Modifier:T83 Modifies:T80
E45	Condition:T84 Name:T85
E46	Modifier:T86 Modifies:T85
E47	Condition:T87 Name:T88 Stability:T48
E49	Condition:T90 Name:T91 Severity:T95 Acuteness:T133
E50	Modifier:T92 Modifies:T91
E51	Modifier:T93 Modifies:T91
E53	Procedure:T96 Name:T97 Stability:T98
E54	Assertion:T99 Asserted:T98
E55	Study:T100 
E56	Assertion:T101 Asserted:E55
E58	Condition:T103 Name:T104
E59	Condition:T105 Name:T106
E60	Condition:T107 Name:T108 Temporality:E63
E61	Assertion:T109 Asserted:E60
E63	Eq-Comparison:T111 Temporal-Period:T112 Value:T113 Temporal-Unit:T114
E64	Condition:T115 Name:T116 Temporality:E3 Temporality2:E4
E65	Modifier:T117 Modifies:T116
E67	Condition:T119 Name:T120 Temporality:E5 Temporality2:E6
E69	Drug:T122 
E70	Drug:T123 Name:T124 Stability:T126
E71	Other:T125 Is-Other:E69
E72	Drug:T127 Name:T128
E73	Drug:T129 Name:T130
E74	Drug:T131 Name:T132
E76	Assertion:T134 Asserted:T126
T1	Eq-Comparison 178 185	Current
T2	Eq-Temporal-Period 178 185	Current
T3	Eq-Comparison 334 341	Current
T4	Eq-Temporal-Period 334 341	Current
T5	Eq-Comparison 1131 1138	current
T6	Eq-Temporal-Period 1131 1138	current
T7	Eq-Comparison 1142 1150	previous
T8	Eq-Temporal-Period 1142 1150	previous
T9	Eq-Comparison 1180 1187	current
T10	Eq-Temporal-Period 1180 1187	current
T11	Eq-Comparison 1191 1199	previous
T12	Eq-Temporal-Period 1191 1199	previous
T13	Eq-Comparison 109 118	within 3y
T15	Eq-Comparison 495 503	2 months
T17	Life-Stage-And-Gender 25 31	Female
T18	Condition 58 71	endometriosis
T19	Condition-Name 58 71	endometriosis
T20	Procedure 37 47	surgically
T21	Procedure-Name 37 47	surgically
T22	Procedure 87 98	laparoscopy
T23	Procedure-Name 87 98	laparoscopy
T24	Eq-Operator 109 115	within
T25	Eq-Value 116 117	3
T26	Eq-Temporal-Unit 117 118	y
T27	Study 128 133	study
T28	Age 148 151	Age
T29	Eq-Comparison 152 172	15 years to 40 years
T30	Eq-Value 152 154	15
T31	Eq-Temporal-Unit 155 160	years
T32	Eq-Operator 161 163	to
T33	Eq-Value 164 166	40
T34	Eq-Temporal-Unit 167 172	years
T35	Eq-Comparison 190 200	≥ 2 months
T36	Eq-Operator 190 191	≥
T37	Eq-Value 192 193	2
T38	Eq-Temporal-Unit 194 200	months
T39	Procedure 213 229	hormonal therapy
T40	Procedure-Name 213 229	hormonal therapy
T41	Procedure 247 266	oral contraceptives
T42	Procedure-Name 247 266	oral contraceptives
T43	Modifier 238 246	combined
T44	Drug 268 289	norethindrone acetate
T45	Drug-Name 268 289	norethindrone acetate
T46	Procedure 294 328	levonorgestrel intrauterine device
T47	Procedure-Name 294 328	levonorgestrel intrauterine device
T49	Observation 349 353	pain
T50	Observation-Name 349 353	pain
T51	Modifier 342 348	pelvic
T53	Eq-Comparison 361 364	≥ 3
T54	Eq-Operator 361 362	≥
T55	Eq-Value 363 364	3
T56	Eq-Comparison 470 485	≥ 14 days/month
T57	Eq-Operator 470 471	≥
T58	Eq-Value 472 474	14
T59	Eq-Temporal-Unit 475 479	days
T60	Eq-Temporal-Unit 480 485	month
T16	Eq-Value 495 496	2
T61	Eq-Temporal-Unit 497 503	months
T63	Study 513 518	study
T65	Assertion 535 546	Willingness
T67	Condition 619 627	menarche
T68	Condition-Name 619 627	menarche
T69	Condition 636 645	menopause
T71	Condition-Name 636 645	menopause
T74	Drug 672 683	cabergoline
T75	Drug-Name 672 683	cabergoline
T76	Contraindication 651 668	Contraindications
T77	Condition 691 713	cardiac valve disorder
T78	Condition-Name 691 713	cardiac valve disorder
T79	Condition 764 772	disorder
T80	Condition-Name 764 772	disorder
T81	Modifier 715 724	pulmonary
T82	Modifier 726 737	pericardial
T83	Modifier 739 763	retroperitoneal fibrotic
T84	Condition 774 790	hypersensitivity
T85	Condition-Name 774 790	hypersensitivity
T86	Modifier 794 811	ergot derivatives
T87	Condition 826 838	hypertension
T88	Condition-Name 826 838	hypertension
T90	Condition 884 891	illness
T91	Condition-Name 884 891	illness
T92	Modifier 857 863	mental
T93	Modifier 875 883	systemic
T95	Severity 845 856	Significant
T96	Procedure 912 927	pain assessment
T97	Procedure-Name 912 927	pain assessment
T98	Stability 903 911	confound
T99	Assertion 897 902	might
T100	Study 959 964	study
T101	Assertion 935 945	ability to
T103	Condition 970 978	Pregnant
T104	Condition-Name 970 978	Pregnant
T105	Condition 980 993	breastfeeding
T106	Condition-Name 980 993	breastfeeding
T107	Condition 1017 1025	pregnant
T108	Condition-Name 1017 1025	pregnant
T109	Assertion 998 1016	planning to become
T111	Eq-Comparison 1033 1046	next 6 months
T112	Eq-Temporal-Period 1033 1037	next
T113	Eq-Value 1038 1039	6
T114	Eq-Temporal-Unit 1040 1046	months
T115	Condition 1123 1129	cancer
T116	Condition-Name 1123 1129	cancer
T117	Modifier 1116 1122	Breast
T119	Condition 1156 1178	Thromboembolic disease
T120	Condition-Name 1156 1178	Thromboembolic disease
T122	Drug 1218 1223	drugs
T123	Drug 1236 1244	dopamine
T124	Drug-Name 1236 1244	dopamine
T125	Other 1212 1217	other
T126	Stability 1229 1235	affect
T127	Drug 1252 1266	phenothiazines
T128	Drug-Name 1252 1266	phenothiazines
T129	Drug 1268 1282	metoclopramide
T130	Drug-Name 1268 1282	metoclopramide
T131	Drug 1284 1298	butyrophenones
T132	Drug-Name 1284 1298	butyrophenones
T133	Acuteness 867 874	chronic
T134	Assertion 1229 1235	affect
A1	Eq-Temporal-Period-Value T2 present
A2	Eq-Temporal-Period-Value T4 present
A3	Eq-Temporal-Period-Value T6 present
A4	Eq-Temporal-Period-Value T8 past
A5	Eq-Temporal-Period-Value T10 present
A6	Eq-Temporal-Period-Value T12 past
A9	Life-Stage-And-Gender-Type T17 female
A10	Eq-Operator-Value T24 LTEQ
A11	Eq-Temporal-Unit-Value T26 year
A12	Eq-Temporal-Unit-Value T31 year
A13	Eq-Operator-Value T32 BETWEEN
A14	Eq-Temporal-Unit-Value T34 year
A15	Eq-Operator-Value T36 GTEQ
A16	Eq-Temporal-Unit-Value T38 month
A17	Eq-Operator-Value T54 GTEQ
A18	Eq-Operator-Value T57 GTEQ
A19	Eq-Temporal-Unit-Value T59 day
A20	Eq-Temporal-Unit-Value T60 month
A8	Eq-Temporal-Unit-Value T61 month
A23	Assertion-Type-Value E31 hypothetical
A26	Severity-Value T95 severe
A27	Stability-Value T98 change
A28	Assertion-Type-Value E54 hypothetical
A29	Assertion-Type-Value E56 hypothetical
A30	Assertion-Type-Value E61 intention
A31	Eq-Temporal-Period-Value T112 future
A32	Eq-Temporal-Unit-Value T114 month
A33	Stability-Value T126 change
A34	Assertion-Type-Value E76 hypothetical
A35	Acuteness-Type-Value T133 chronic
R1	Found-By Arg1:E9 Arg2:E10
R2	Found-By Arg1:E9 Arg2:E11
R3	Example-Of Arg1:E18 Arg2:E17
R4	Example-Of Arg1:E20 Arg2:E17
R5	Example-Of Arg1:E21 Arg2:E17
R6	Example-Of Arg1:E40 Arg2:E39
R7	Example-Of Arg1:E41 Arg2:E39
R8	Example-Of Arg1:E45 Arg2:E39
R9	Example-Of Arg1:E47 Arg2:E39
R10	Caused-By Arg1:T98 Arg2:E49
R11	Caused-By Arg1:T126 Arg2:E69
R12	Example-Of Arg1:E72 Arg2:E69
R13	Example-Of Arg1:E73 Arg2:E69
R14	Example-Of Arg1:E74 Arg2:E69
R15	Before Arg1:E7 Arg2:E13
R16	Or Arg1:E20 Arg2:E21
R17	During Arg1:E23 Arg2:E8
R18	Before Arg1:E8 Arg2:E29
R19	Or Arg1:E33 Arg2:E34
R20	Or Arg1:E50 Arg2:E51
R21	Or Arg1:E53 Arg2:E56
R22	Or Arg1:E59 Arg2:E61
R23	Or Arg1:E3 Arg2:E4
R24	Or Arg1:E5 Arg2:E6
R25	Or Arg1:E18 Arg2:E20
R26	Or Arg1:E42 Arg2:E43
R27	Or Arg1:E43 Arg2:E44
R28	Or Arg1:E58 Arg2:E59
R29	Or Arg1:E72 Arg2:E73
R30	Or Arg1:E73 Arg2:E74
T14	Encounter 562 567	visit
E12	Encounter:T14 
A7	Encounter-Type-Value E12 outpatient
T48	Stability 813 825	uncontrolled
A21	Stability-Value T48 change
